Researchers used gradient boosting machines to develop a radiomics model for CD40LG prediction, evaluating it with operating characteristic curves, decision curves, and the Hosmer-Lemeshow test.<h4>Results</h4>The study found that CD40LG levels were significantly lower in HNSCC tissues than healthy ones. The gene discussed is CD40LG; the disease is head and neck squamous cell carcinoma.